Filing Flows › Akebia Therapeutics (AKBA) › Net income
Akebia Therapeutics (AKBA) net income by quarter
Akebia Therapeutics' net income was $540K in Q3 2025 (third quarter 2025), +119% from Q2 2025. Over the last 3 quarters it ranged from $247K (Q2 2025) to $6.1M (Q1 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | $540K | +119% | — |
| Q2 2025 | $247K | -96% | — |
| Q1 2025 | $6.1M | — | — |
Q3 2025 at a glance
Akebia Therapeutics, Q3 2025: revenue $58.8M (+57% year over year), operating margin 7.6%, net earnings $540K, operating cash flow $28.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Akebia Therapeutics' net income?
Akebia Therapeutics' net income was $540K in Q3 2025 (third quarter 2025), +119% from Q2 2025.
How has Akebia Therapeutics' net income changed?
Over the last 3 quarters it ranged from $247K (Q2 2025) to $6.1M (Q1 2025).